Cellectis (CLLS) Tops Q2 EPS by 1c

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $3.47 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance
• Are we witnessing a fundamental or speculative rally in the S&P 500?